Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

FDA Decision Looms for Stealth BioTherapeutics' Elamipretide in Ultra-Rare Barth Syndrome

The pharmaceutical industry holds its breath as the U.S. Food and Drug Administration (FDA) approaches a critical decision on Stealth BioTherapeutics' elamipretide, a potential first-ever treatment for Barth syndrome. With the target review date set for September 26, 2025, the outcome could mark a significant milestone for both the biotech company and the small community of patients affected by this ultra-rare mitochondrial disease.

NoahAI News9/17/2025

Novo Nordisk and Eli Lilly Intensify Competition in Obesity Treatment Market

In a rapidly evolving landscape of obesity treatments, pharmaceutical giants Novo Nordisk and Eli Lilly are making strategic moves to secure their positions at the forefront of the market. Recent developments, unveiled at the 2025 European Association for the Study of Diabetes (EASD) conference, highlight the intensifying competition between these industry leaders.

NoahAI News9/17/2025

Innovaccer Acquires Story Health, Expanding AI-Driven Specialty Care Offerings

Innovaccer, a healthcare technology and AI company, has announced its acquisition of Story Health, a digital specialty care platform. The move, revealed on Tuesday, aims to enhance Innovaccer's Healthcare Intelligence Cloud offering and expand its reach in the specialty care market. Financial terms of the deal were not disclosed.

NoahAI News9/17/2025

Kennedy Appoints New ACIP Members with Vaccine Skepticism Backgrounds Ahead of Crucial Meeting

Health Secretary Robert F. Kennedy, Jr. has named five new members to the CDC's Advisory Committee on Immunization Practices (ACIP), sparking controversy due to several appointees' documented histories of vaccine and COVID-19 skepticism. This development comes just days before a critical ACIP meeting scheduled to discuss and make recommendations on various vaccines, including COVID-19.

NoahAI News9/17/2025

Leadership Changes and Financial Updates in Diabetes Tech Companies

Insulet, a prominent player in diabetes technology, has announced the appointment of Flavia Pease as its new Chief Financial Officer, effective September 30, 2025. Pease, who previously served as CFO at Charles River Laboratories, brings over two decades of experience from Johnson & Johnson, where she held key roles in both medical device and pharmaceutical segments.

NoahAI News9/17/2025

Thermo Fisher Unveils Advanced Protein Panel for Neurodegenerative Disease Research

Thermo Fisher Scientific has launched a cutting-edge research test designed to profile multiple proteins associated with neurodegenerative diseases, marking a significant advancement in the field of proteomics and biomarker discovery. The new multiplex immunoassay panel, integrated into the company's Target 48 proteomics line, aims to accelerate the development of clinical biomarkers for conditions such as Alzheimer's, Parkinson's, ALS, and multiple sclerosis.

NoahAI News9/17/2025

CSL Secures Option to Acquire VarmX, Targeting Blood Clotting Drug Market

Australian pharmaceutical giant CSL has struck a deal with Dutch biotechnology startup VarmX, securing an option to acquire the company and its promising blood clotting drug. This strategic move aligns with CSL's recent restructuring efforts and signals a potential expansion in the anticoagulant reversal agent market.

NoahAI News9/17/2025

Genmab Discontinues ADC from ProfoundBio Acquisition, Continues Development of Other Assets

Genmab, a prominent player in the biotechnology industry, has announced the discontinuation of an antibody-drug conjugate (ADC) acquired through its $1.8 billion purchase of ProfoundBio last year. The company cited an inadequate benefit-risk profile as the reason for halting the development of GEN1107, a protein tyrosine K 7 (PTK7)-targeted ADC that was being evaluated in a phase 1/2 cancer trial.

NoahAI News9/17/2025

Healthcare Workers Consider Job Changes Amid Burnout and Dissatisfaction

In a concerning development for the healthcare industry, a recent survey conducted by the Harris Poll reveals that over half of healthcare workers are contemplating leaving their current positions within the next year. This potential exodus of talent comes at a time when the sector is already grappling with widespread staffing shortages and increasing demand for services.

NoahAI News9/17/2025

Foundation Models Reshape Radiology AI Landscape: Industry Leaders Navigate Development and Regulation

The radiology sector is witnessing a significant shift as companies race to develop and implement foundation models, a new breed of artificial intelligence (AI) that promises greater accuracy and faster development in medical imaging. This emerging technology is poised to transform the way radiologists work, potentially addressing ongoing challenges such as increasing workloads and clinician shortages.

NoahAI News9/17/2025

Apollo's IL-18 Antibody Shows Promise in Phase 2 Eczema Trial

Apollo Therapeutics' strategic investment in an anti-IL-18 monoclonal antibody has yielded positive results in a recent phase 2 clinical trial for atopic dermatitis (AD). The study, which involved 62 patients with moderate to severe AD in the United States and Canada, demonstrated significant efficacy and potential advantages over existing treatments.

NoahAI News9/17/2025

Areteia Therapeutics Reports Positive Phase 3 Results for Oral Asthma Treatment

Areteia Therapeutics has announced promising results from its phase 3 clinical trial, Exhale-4, for dexpramipexole, a potential oral alternative to injectable biologics in the treatment of eosinophilic asthma. The study met its primary endpoint, demonstrating significant improvement in lung function compared to placebo.

NoahAI News9/17/2025

«1...56 57 58...67 »